264.99 USD
↗ 1.79 (0.68%)PRE MARKET (AS OF 07:03 AM EDT)
Shares of ABBVIE INC. (ABBV) are trading at $264.99. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jul 28, 2026.
Open?$264.95
High?$266.45
Low?$263.41
Prev. Close?$263.20
Volume?1.6K
Avg. Volume?8.2M
VWAP?$265.23
Rel. Volume?0.00x
Bid / Ask
Bid?$260.00 × 100
Ask?$267.50 × 100
Spread?$7.50
Midpoint?$263.75
Valuation & Ratios
Market Cap?465.0B
Shares Out?1.8B
Float?1.8B
Float %?100.0%
P/E Ratio?128.99
P/B Ratio?-69.86
EPS?$2.04
Dividend?2.54%
Ex-Dividend?N/A
News
Profile
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Themes
Employees
57.0K
Market Cap
453.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-12-10
Address
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
Phone: (847) 932-7900
NORTH CHICAGO, IL 60064
Phone: (847) 932-7900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?54
Momentum?38
Short Sent.?57
Piotroski F-Score?6/9Mixed
Altman Z-Score?2.52Grey
Confidence?74%Moderate
Short InterestModerate
Short % of Float?1.28%Low
Short Interest?22.6M
Days to Cover?3.5
Free Float1.8B
Avg Daily Volume6.6M
Settlement Date2026-07-15
Financial Health
Current Ratio?0.80Weak
Quick Ratio?0.68Weak
Cash Ratio?0.22Low
Debt/Equity?-10.95Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score56/100
P/E?129.0PRICEY▾
Peers20
S&P3
P/B?-69.86CHEAP▾
Peers100
S&P97
P/S?7.40HIGH▾
Peers36
S&P16
P/FCF?21.6FAIR▾
Peers67
S&P50
EV/EBITDA?18.5FAIR▾
Peers60
S&P32
EV/Sales?8.41HIGH▾
Peers36
S&P16
Returns & Efficiency
ROE?-54.2%WEAK▾
Peers10
S&P3
ROA?2.6%WEAK▾
Peers20
S&P25
Cash Flow & Enterprise
FCF?$21.5B
Enterprise Value?$528.5B
Fundamentals ratios updated end of day